Background MicroRNAs (miRNAs), the key regulator of gene expression, and N6‐
methyladenosine (m6A) RNA modification play a significant role in tumour progression …

Objectives Micro RNA s (mi RNA s) as small noncoding RNA molecules function by
regulating their target genes negatively. MiR‐1258 was widely researched in multicancers …

ABSTRACT N (6)-methyladenosine (m6A)-modified microRNAs (miRNAs) are relevant to
cancer progression. Also, although the involvement of miR-380-3p in regulating cancer …

Background Colorectal cancer (CRC) is a common malignant tumor with high metastatic and
recurrent rates. This study probes the effect and mechanism of long non-coding RNA …

N 6-Methyladenosine (m 6 A) is a prevalent modification present in the mRNAs of higher
eukaryotes. YTH domain family 2 (YTHDF2), an m 6 A" reader" protein, can recognize …

Recent studies have suggested that microRNA let-7i is a tumor suppressor in human
cancers, including esophageal cancer, but its underlying mechanism is not yet fully …

Colorectal cancer (CRC) is one of the leading cancer-related causes of death in the world.
Recently, downregulation of microRNA-497 (miR-497) has been observed in CRC tissues …

Recent studies that have emerged on the diversity of RNA modification in tumors suggest
their eligibility as bona fide targets in diagnosis and drug discovery. N6-methyladenosine (m …

Long non‐coding RNAs (lncRNAs) have recently emerged as key regulators of the
occurrence and progression of various human cancers, including colorectal cancer …

Aberrant expression of microRNAs (miRNAs) and its dysfunction have been revealed as
crucial modulators of cancer initiation and progression. MiR-129-2 has been reported to play …